Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Cipla
Merck
AstraZeneca
Moodys
Baxter

Generated: March 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for CERC-301

« Back to Dashboard

US Patents for CERC-301

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
CERC-301 ➤ Sign Up 3-fluoro-piperidines as NMDA/NR2B antagonists Merck & Co., Inc. (Rahway, NJ) ➤ Sign Up
CERC-301 ➤ Sign Up Methods for treating Parkinson's disease UCB Biopharma SPRL (Brussels, BE) ➤ Sign Up
CERC-301 ➤ Sign Up Pyrrolopyrimidine derivatives as NR2B NMDA receptor antagonists Rugen Holdings (Cayman) Limited (Grand Cayman, KY) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for CERC-301

Drugname Country Document Number Estimated Expiration Related US Patent
CERC-301 Argentina 044579 2023-06-04 ➤ Sign Up
CERC-301 Austria 403651 2023-06-04 ➤ Sign Up
CERC-301 Australia 2004245522 2023-06-04 ➤ Sign Up
CERC-301 Brazil PI0410837 2023-06-04 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Healthtrust
Johnson and Johnson
UBS
Colorcon
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.